Nippon Kayaku Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Nippon Kayaku Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Nippon Kayaku Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Nippon Kayaku Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Nippon Kayaku Co Ltd (Nippon Kayaku) is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals, safety systems and agrochemicals. Major products portfolio includes epoxy resins, UV-curing type resins, optical functional films, colors for inkjet printers, catalysts, pharmaceuticals, active pharmaceutical ingredients, intermediates, diagnostic drugs, safety systems such as airbag inflators, micro gas generators for seatbelt pretensioners, squibs, agrochemicals, dyes and others. Its products serve to various industries, including automotive, electronics, and healthcare, providing essential components and solutions. The company collaborates with channel partners and utilizes distribution networks. Nippon Kayaku has a presence in multiple geographic locations, including the UK, Germany, Netherlands, Thailand, Malaysia, Korea, Taiwan, Japan, the US, Mexico and China, targeting markets across different regions. Nippon Kayaku is headquartered in Chiyoda-ku, Tokyo, Japan.
Headquarters
Japan
Address
Meiji Yasuda Seimei Building 19th and 20th Floors, 1-1, Marunouchi 2-chome, Chiyoda-ku, Tokyo, 100-0005
Website
www.nipponkayaku.co.jp
Telephone
81 3 67315200
No of Employees
5,979
Industry
Chemicals
Ticker Symbol & Exchange
4272 (TYO)
Revenue (2025)
$1.5B
10.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
325.7%
(2025 vs 2024)
Market Cap*
$1.8B
Net Profit Margin (2025)
XYZ
285.8%
(2025 vs 2024)
* As of and is in US$
Nippon Kayaku Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| UV-curing Type Resins | Bren |
| Optical Functional Films | Coforin |
| Colors for Inkjet Printers | Carboplaten |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In March, the company partnered with GlycoNex Inc. to advance GNX201-ADC, an antibody-drug conjugate candidate for the treatment of solid tumors. |
| 2026 | Contracts/Agreements | In February, the company, Sysmex Corp, and Hikari Tsushin signed an agreement to sell KAINOS Laboratories, Inc. to Denka Company Limited and Flowers Co., Ltd. |
| 2025 | New Products/Services | In November, the company launched oncology medicine “IBTROZI Capsules 200mg. |
Competitor Comparison
| Key Parameters | Nippon Kayaku Co Ltd | Astellas Pharma Inc | Daiichi Sankyo Co Ltd | Eisai Co Ltd | Yakult Honsha Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Chiyoda-Ku | Chuo-Ku | Chuo-Ku | Bunkyo-Ku | Minato-Ku |
| State/Province | Tokyo | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | 5,979 | 13,643 | 19,765 | 13,506 | 2,810 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kenichiro Yoshioka | Chief Executive Officer - KAYAKU Advanced Materials, inc.; Director; President | Executive Board | - | - |
| Shigeyuki Kawamura | Director; President | Executive Board | 2025 | 63 |
| Shinji Inoue | Director; Head of Corporate Planning Division, Corporate Communications Division, Finance & Accounting Division and Information Systems Division | Executive Board | 2025 | 60 |
| Hiroshi Shimada | Director; General Manager of Life Science Business Unit; Head of Pharmaceuticals Group | Executive Board | 2024 | 61 |
| Yasuhito Kato | Director; Technology Unit | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer